Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Head and Neck Cancer

Free Subscription Articles published in Cancer Retrieve available abstracts of 93 articles: HTML format

Single Articles

March 2024
1. HO AL, Foster NR, Deraje Vasudeva S, Katabi N, et al
   A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).
   Cancer. 2024;130:702-712.
   PubMed     Abstract available
   
   
   February 2024
2. CHOI H, Cho SW, Kim HH, Yi KH, et al
   Shortened telomere length in peripheral blood leukocytes is associated with cumulative radioactive iodine doses in patients with differentiated thyroid carcinoma.
   Cancer. 2024 Feb 20. doi: 10.1002/cncr.35256.
   PubMed     Abstract available
   
   
   
3. DE ALMEIDA JR, Su JS, Kolarski MM, Truong T, et al
   Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma.
   Cancer. 2024;130:410-420.
   PubMed     Abstract available
   
   
   January 2024
4. GROSS ND, Seiwert TY
   Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?
   Cancer. 2024 Jan 18. doi: 10.1002/cncr.35198.
   PubMed    
   
   
   
5. NIERENGARTEN MB
   Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer.
   Cancer. 2024;130:172.
   PubMed    
   
   
   
6. NIERENGARTEN MB
   Oral health linked to survival in head and neck cancer.
   Cancer. 2024;130:171.
   PubMed    
   
   
   December 2023
7. 
   Researchers identify two new subtypes of HPV-associated head and neck cancers.
   Cancer. 2023;129:3842.
   PubMed    
   
   
   October 2023
8. CARPENTER DJ, Patel P, Niedzwiecki D, Dillon M, et al
   Long-term risk of carotid stenosis and cerebrovascular disease after radiation therapy for head and neck cancer.
   Cancer. 2023 Oct 28. doi: 10.1002/cncr.35089.
   PubMed     Abstract available
   
   
   
9. MORAND GB, Eskander A, Fu R, de Almeida J, et al
   The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative.
   Cancer. 2023;129:3263-3274.
   PubMed     Abstract available
   
   
   
10. PHILIPS R, Alnemri A, Amin D, Patel J, et al
    Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.
    Cancer. 2023 Oct 3. doi: 10.1002/cncr.35045.
    PubMed     Abstract available
    
    
    September 2023
11. ZHANG L, San Valentin EMD, John TM, Jenq RR, et al
    Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2023 Sep 8. doi: 10.1002/cncr.35001.
    PubMed     Abstract available
    
    
    July 2023
12. PATEL SA, Gibson MK, Deal A, Sheth S, et al
    A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma.
    Cancer. 2023 Jul 3. doi: 10.1002/cncr.34930.
    PubMed     Abstract available
    
    
    May 2023
13. FAN JH, Sun WY, Yang H, Wang XK, et al
    Short-term and long-term effect of nutrition intervention in the Linxian Dysplasia Nutrition Intervention Trial and the reason for disappearance of the intervention effect: A cohort study.
    Cancer. 2023 May 27. doi: 10.1002/cncr.34761.
    PubMed     Abstract available
    
    
    
14. HARING CT, Kana LA, Dermody SM, Brummel C, et al
    Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
    Cancer. 2023 May 10. doi: 10.1002/cncr.34823.
    PubMed     Abstract available
    
    
    
15. 
    Erratum to "Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma".
    Cancer. 2023 May 2. doi: 10.1002/cncr.34829.
    PubMed    
    
    
    
16. RAMKUMAR SP, Simpson MC, Adjei Boakye E, Bukatko AR, et al
    High-risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma.
    Cancer. 2023;129:1372-1383.
    PubMed     Abstract available
    
    
    April 2023
17. YAN L, Li Y, Li XY, Xiao J, et al
    Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
    Cancer. 2023 Apr 15. doi: 10.1002/cncr.34802.
    PubMed     Abstract available
    
    
    
18. D'SOUZA G, Tewari SR, Troy T, Waterboer T, et al
    Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
    Cancer. 2023 Apr 9. doi: 10.1002/cncr.34783.
    PubMed     Abstract available
    
    
    March 2023
19. WILLIAM WN JR, Zhang J, Zhao X, Parra ER, et al
    Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
    Cancer. 2023;129:714-727.
    PubMed     Abstract available
    
    
    February 2023
20. OH DY, Algazi A, Capdevila J, Longo F, et al
    Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
    Cancer. 2023 Feb 7. doi: 10.1002/cncr.34657.
    PubMed     Abstract available
    
    
    
21. QUAN DL, Grauer JS, Sunkara PR, Cramer JD, et al
    Surgical salvage of human papillomavirus-positive oropharyngeal cancer: Secondary analysis of a randomized controlled trial.
    Cancer. 2023;129:376-384.
    PubMed     Abstract available
    
    
    January 2023
22. VERMA A, Burtness B
    Top advances of the year: Head and neck cancer.
    Cancer. 2023 Jan 24. doi: 10.1002/cncr.34654.
    PubMed     Abstract available
    
    
    
23. LEE JJW, Kunaratnam V, Kim CJH, Pienkowski M, et al
    Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.
    Cancer. 2023 Jan 18. doi: 10.1002/cncr.34620.
    PubMed     Abstract available
    
    
    November 2022
24. KOYUNCU CF, Nag R, Lu C, Corredor G, et al
    Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Cancer. 2022;128:3831-3842.
    PubMed     Abstract available
    
    
    October 2022
25. BROSE MS, Robinson BG, Sherman SI, Jarzab B, et al
    Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
    Cancer. 2022 Oct 19. doi: 10.1002/cncr.34493.
    PubMed     Abstract available
    
    
    
26. JACKSON SS, Marks MA, Katki HA, Cook MB, et al
    Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors.
    Cancer. 2022;128:3531-3540.
    PubMed     Abstract available
    
    
    
27. 
    Sharp rise in esophageal cancer and Barrett esophagus seen in middle-aged people.
    Cancer. 2022;128:3584-3585.
    PubMed    
    
    
    August 2022
28. LIN Y, Bruner DW, Paul S, Miller AH, et al
    A network analysis of self-reported psychoneurological symptoms in patients with head and neck cancer undergoing intensity-modulated radiotherapy.
    Cancer. 2022 Aug 15. doi: 10.1002/cncr.34424.
    PubMed     Abstract available
    
    
    July 2022
29. MAZUL AL, Hartman CM, Mowery YM, Kramer JR, et al
    Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
    Cancer. 2022 Jul 22. doi: 10.1002/cncr.34387.
    PubMed     Abstract available
    
    
    
30. HSUEH CY, Lau HC, Huang Q, Gong H, et al
    Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2022 Jul 5. doi: 10.1002/cncr.34338.
    PubMed     Abstract available
    
    
    June 2022
31. 
    Erratum to "Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study".
    Cancer. 2022 Jun 24. doi: 10.1002/cncr.34358.
    PubMed    
    
    
    
32. FAN JH, Wang JB, Yang H, Dawsey SM, et al
    Mortality after multivitamin supplementation: Nearly 35-year follow-up of the randomized Linxian Dysplasia Nutrition Intervention Trial.
    Cancer. 2022 Jun 7. doi: 10.1002/cncr.34344.
    PubMed     Abstract available
    
    
    
33. O'BOYLE CJ, Siravegna G, Varmeh S, Queenan N, et al
    Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2022;128:2193-2204.
    PubMed     Abstract available
    
    
    May 2022
34. HUANG SH, Jacinto JCK, O'Sullivan B, Su J, et al
    Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
    Cancer. 2022 May 19. doi: 10.1002/cncr.34266.
    PubMed     Abstract available
    
    
    
35. NELSON TJ, Thompson CA, Zou J, Kumar A, et al
    Validation of NRG Oncology's prognostic nomograms for oropharyngeal cancer in the Veterans Affairs database.
    Cancer. 2022;128:1948-1957.
    PubMed     Abstract available
    
    
    
36. COWZER D, Janjigian YY
    Top advances in esophageal/gastroesophageal junction cancers in 2021.
    Cancer. 2022;128:1894-1899.
    PubMed    
    
    
    
37. LI Y, Yao F, Jiao Z, Su X, et al
    Cyclin-dependent kinase 5 promotes the growth of tongue squamous cell carcinoma through the microRNA 513c-5p/cell division cycle 25B pathway and is associated with a poor prognosis.
    Cancer. 2022;128:1775-1786.
    PubMed     Abstract available
    
    
    April 2022
38. KIYOTA N, Tahara M, Robinson B, Schlumberger M, et al
    Impact of baseline tumor burden on overall survival in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the SELECT global phase 3 trial.
    Cancer. 2022 Apr 5. doi: 10.1002/cncr.34181.
    PubMed     Abstract available
    
    
    
39. HUTCHESON KA, Barbon CEA, Alvarez CP, Warneke CL, et al
    Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2.
    Cancer. 2022;128:1458-1466.
    PubMed     Abstract available
    
    
    March 2022
40. PARK S, Oh D, Choi YL, Chi SA, et al
    Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Cancer. 2022 Mar 23. doi: 10.1002/cncr.34176.
    PubMed     Abstract available
    
    
    
41. SOO J, Jin MC, Beadle BM, Holsinger FC, et al
    Circulating tumor DNA in head and neck cancer: Early successes and future promise.
    Cancer. 2022 Mar 17. doi: 10.1002/cncr.34189.
    PubMed     Abstract available
    
    
    
42. CHUNG HC, Kang YK, Chen Z, Bai Y, et al
    Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients.
    Cancer. 2022;128:995-1003.
    PubMed     Abstract available
    
    
    February 2022
43. EKANAYAKE WEERAMANGE C, Shu D, Tang KD, Batra J, et al
    Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Cancer. 2022 Feb 17. doi: 10.1002/cncr.34148.
    PubMed     Abstract available
    
    
    
44. OLIVER JR, Persky MJ, Wang B, Duvvuri U, et al
    Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers.
    Cancer. 2022;128:685-696.
    PubMed     Abstract available
    
    
    
45. SCOTT-WITTENBORN N, D'Souza G, Tewari S, Rooper L, et al
    Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
    Cancer. 2022 Feb 8. doi: 10.1002/cncr.34124.
    PubMed     Abstract available
    
    
    
46. SOUSA LG, Wang K, Torman D, Binks BJ, et al
    Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified.
    Cancer. 2022;128:509-518.
    PubMed     Abstract available
    
    
    January 2022
47. BALACHANDRA S, Eary RL, Lee R, Wynings EM, et al
    Substance use and mental health burden in head and neck and other cancer survivors: A National Health Interview Survey analysis.
    Cancer. 2022;128:112-121.
    PubMed     Abstract available
    
    
    December 2021
48. LIANG L, Liu Z, Zhu H, Wang H, et al
    Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
    Cancer. 2021 Dec 15. doi: 10.1002/cncr.34074.
    PubMed     Abstract available
    
    
    
49. WOTMAN MT, Miles BA, Bakst RL, Posner MR, et al
    A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Cancer. 2021;127:4330-4338.
    PubMed    
    
    
    
50. AGGARWAL P, Hutcheson KA, Garden AS, Mott FE, et al
    Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.
    Cancer. 2021;127:4470-4480.
    PubMed     Abstract available
    
    
    October 2021
51. TREISTER NS, Brennan MT, Sollecito TP, Schmidt BL, et al
    Exposed bone in patients with head and neck cancer treated with radiation therapy: An analysis of the Observational Study of Dental Outcomes in Head and Neck Cancer Patients (OraRad).
    Cancer. 2021 Oct 19. doi: 10.1002/cncr.33948.
    PubMed     Abstract available
    
    
    
52. REN J, Pang W, Hueniken K, Haddad G, et al
    Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
    Cancer. 2021 Oct 1. doi: 10.1002/cncr.33936.
    PubMed     Abstract available
    
    
    
53. FAKHRY C, Tewari SR, Zhang L, Windon MJ, et al
    RTOG-0129 risk groups are reproducible in a prospective multicenter heterogeneously treated cohort.
    Cancer. 2021;127:3523-3530.
    PubMed     Abstract available
    
    
    September 2021
54. FOSTER CC, Couey MA, Kochanny SE, Khattri A, et al
    Immune-related adverse events are associated with improved response, progression-free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors.
    Cancer. 2021 Sep 21. doi: 10.1002/cncr.33780.
    PubMed     Abstract available
    
    
    
55. ABDELMEGUID AS, Hanna EY
    Reply to Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3265.
    PubMed    
    
    
    
56. PANDA S, Raveendran S, Kumar R, Thakar A, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses-Is it worthwhile?
    Cancer. 2021;127:3264.
    PubMed    
    
    
    
57. WU J, Xiao F, Zheng Y, Lin Y, et al
    Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
    Cancer. 2021;127:3172-3182.
    PubMed     Abstract available
    
    
    
58. RYAN WR, Xu MJ, Ochoa E, Plonowska-Hirschfeld KA, et al
    Oncologic outcomes of human papillomavirus-associated oropharynx carcinoma treated with surgery alone: A 12-institution study of 344 patients.
    Cancer. 2021;127:3092-3106.
    PubMed     Abstract available
    
    
    
59. ABDELMEGUID AS, Silver NL, Boonsripitayanon M, Glisson BS, et al
    Role of induction chemotherapy for oral cavity squamous cell carcinoma.
    Cancer. 2021;127:3107-3112.
    PubMed     Abstract available
    
    
    August 2021
60. SEAMAN AT, Seligman KL, Nguyen KK, Al-Qurayshi Z, et al
    Characterizing head and neck cancer survivors' discontinuation of survivorship care.
    Cancer. 2021 Aug 30. doi: 10.1002/cncr.33888.
    PubMed     Abstract available
    
    
    
61. HARDMAN JC, Tikka T, Paleri V
    Remote triage incorporating symptom-based risk stratification for suspected head and neck cancer referrals: A prospective population-based study.
    Cancer. 2021 Aug 19. doi: 10.1002/cncr.33800.
    PubMed     Abstract available
    
    
    
62. GUO TW, Saiyed F, Yao CMKL, Kiong KL, et al
    Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
    Cancer. 2021;127:2916-2925.
    PubMed     Abstract available
    
    
    
63. CHERA BS, Sheth SH, Patel SA, Goldin D, et al
    Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma.
    Cancer. 2021 Aug 11. doi: 10.1002/cncr.33789.
    PubMed     Abstract available
    
    
    
64. AMIT M, Liu C, Mansour J, Gleber-Netto FO, et al
    Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma.
    Cancer. 2021 Aug 6. doi: 10.1002/cncr.33773.
    PubMed     Abstract available
    
    
    
65. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    PubMed     Abstract available
    
    
    July 2021
66. YU KJ, Hsu WL, Chiang CJ, Chen TC, et al
    Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years.
    Cancer. 2021 Jul 29. doi: 10.1002/cncr.33799.
    PubMed     Abstract available
    
    
    
67. ROMESSER PB, Sherman EJ, Whiting K, Ho ML, et al
    Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial.
    Cancer. 2021 Jul 22. doi: 10.1002/cncr.33804.
    PubMed     Abstract available
    
    
    
68. VAN DIJK LV, Mohamed ASR, Ferrarotto R, McCoy LA, et al
    The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry.
    Cancer. 2021;127:2453-2464.
    PubMed     Abstract available
    
    
    
69. WHITMARSH A, Pring M, Thomas SJ, Waylen A, et al
    Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Cancer. 2021;127:2442-2452.
    PubMed     Abstract available
    
    
    
70. XIAO Q, Kitahara CM
    Reply to associations between light at night and risk of thyroid cancer.
    Cancer. 2021 Jul 10. doi: 10.1002/cncr.33685.
    PubMed    
    
    
    
71. XIAO P, Li L, Ding S, Xie J, et al
    Associations between light at night and risk of thyroid cancer.
    Cancer. 2021 Jul 10. doi: 10.1002/cncr.33686.
    PubMed    
    
    
    
72. LIU Z, Li H, Yu KJ, Xie SH, et al
    Comparison of new magnetic resonance imaging grading system with conventional endoscopy for the early detection of nasopharyngeal carcinoma.
    Cancer. 2021 Jul 7. doi: 10.1002/cncr.33552.
    PubMed     Abstract available
    
    
    June 2021
73. FU TS, Scheffler P, Forner D, Noel CW, et al
    A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
    Cancer. 2021 Jun 1. doi: 10.1002/cncr.33653.
    PubMed     Abstract available
    
    
    
74. SABA NF
    Preoperative chemotherapy for sinonasal squamous cell carcinoma (SNSCC): Time to move closer to a definitive answer.
    Cancer. 2021;127:1734-1735.
    PubMed    
    
    
    
75. ABDELMEGUID AS, Teeramatwanich W, Roberts DB, Amit M, et al
    Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
    Cancer. 2021;127:1788-1795.
    PubMed     Abstract available
    
    
    May 2021
76. RUAN X, Liang JH, Pan Y, Cai R, et al
    Apatinib for the treatment of metastatic or locoregionally recurrent nasopharyngeal carcinoma after failure of chemotherapy: A multicenter, single-arm, prospective phase 2 study.
    Cancer. 2021 May 27. doi: 10.1002/cncr.33626.
    PubMed     Abstract available
    
    
    
77. XIAO C, Beitler JJ, Peng G, Levine ME, et al
    Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study.
    Cancer. 2021 May 24. doi: 10.1002/cncr.33641.
    PubMed     Abstract available
    
    
    
78. JUNG YS, Seok J, Hong S, Ryu CH, et al
    The emergence of oral cavity cancer and the stabilization of oropharyngeal cancer: Recent contrasting epidemics in the South Korean population.
    Cancer. 2021;127:1638-1647.
    PubMed     Abstract available
    
    
    
79. SHANMUGAM A, Hariharan AK, Hasina R, Nair JR, et al
    Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma.
    Cancer. 2021;127:1576-1589.
    PubMed     Abstract available
    
    
    
80. WEISS JM
    Surgery alone for transorally resected human papillomavirus-driven head and neck cancer-Can we de-intensify adjuvant therapy to 0 Gy and 0 mg/m(2) ?
    Cancer. 2021 May 6. doi: 10.1002/cncr.33610.
    PubMed     Abstract available
    
    
    April 2021
81. DAHLSTROM KR, Song J, Thall PF, Fuller CD, et al
    Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.
    Cancer. 2021;127:1228-1237.
    PubMed     Abstract available
    
    
    
82. CHEN Y, Chang ET, Liu Q, Cai Y, et al
    Occupational exposures and risk of nasopharyngeal carcinoma in a high-risk area: A population-based case-control study.
    Cancer. 2021 Apr 6. doi: 10.1002/cncr.33536.
    PubMed     Abstract available
    
    
    
83. THOMAS GR
    Racial disparity in head and neck cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33555.
    PubMed    
    
    
    
84. VOORA RS, Kotha NV, Kumar A, Qiao EM, et al
    Association of Race and Health Care System With Disease Stage and Survival in Veterans With Larynx Cancer.
    Cancer. 2021 Apr 2. doi: 10.1002/cncr.33557.
    PubMed     Abstract available
    
    
    
85. DRAKE VE, Fakhry C, Windon MJ, Stewart CM, et al
    Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Cancer. 2021;127:1029-1038.
    PubMed     Abstract available
    
    
    March 2021
86. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    PubMed     Abstract available
    
    
    February 2021
87. HO AS, Luu M, Kim S, Tighiouart M, et al
    Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
    Cancer. 2021 Feb 17. doi: 10.1002/cncr.33414.
    PubMed     Abstract available
    
    
    
88. CAMPBELL BR, Chen Z, Faden DL, Agrawal N, et al
    The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma.
    Cancer. 2021;127:544-553.
    PubMed     Abstract available
    
    
    
89. ZHANG D, Jones RR, James P, Kitahara CM, et al
    Associations between artificial light at night and risk for thyroid cancer: A large US cohort study.
    Cancer. 2021 Feb 8. doi: 10.1002/cncr.33392.
    PubMed     Abstract available
    
    
    
90. YIP L, Gooding WE, Nikitski A, Wald AI, et al
    Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study.
    Cancer. 2021 Feb 4. doi: 10.1002/cncr.33421.
    PubMed     Abstract available
    
    
    
91. STRACHNA O, Cohen MA, Allison MM, Pfister DG, et al
    Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunities.
    Cancer. 2021;127:359-371.
    PubMed     Abstract available
    
    
    January 2021
92. ALHUMAIDI H, Manochakian R, Cochuyt J, Chindris A, et al
    Initial treatment of patients with thyroid cancer: Outcomes and factors associated with care at academic versus nonacademic cancer centers.
    Cancer. 2021 Jan 15. doi: 10.1002/cncr.33408.
    PubMed     Abstract available
    
    
    June 2020
93. BROUGHMAN JR, Xiong DD, Moeller BJ, Contrera KJ, et al
    Rethinking the 10-pack-year rule for favorable human papillomavirus-associated oropharynx carcinoma: A multi-institution analysis.
    Cancer. 2020;126:2784-2790.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.